EMA Withdrawn: Pantecta Control (pantoprazole) — Takeda GmbH

View source ↗

Summary

EMA confirms withdrawal of Pantecta Control (pantoprazole) from the market by Takeda GmbH, related to gastroesophageal reflux treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Pantecta Control (pantoprazole)

Snippet

Status: Withdrawn. Therapeutic area: Gastroesophageal Reflux. MAH: Takeda GmbH. Decision date: 19/09/2016